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External beam radiation therapy (XRT) has become one of the cornerstones in the management of pediatric oncology cases. While
the procedure itself is painless, the anxiety it causes may necessitate the provision of sedation or anesthesia for the patient. This
review paper will brieﬂy review the XRT procedure itself so that the anesthesia provider has an understanding of what is occurring
during the simulation and treatment phases. We will then examine several currently used regimens for the provision of pediatric
sedation in the XRT suite as well as a discussion of when and how general anesthesia should be performed if deemed necessary.
Standards of care with respect to patient monitoring will be addressed. We will conclude with a survey of the developing ﬁeld of
radiation-based therapy administered outside of the XRT suite.
1.Introduction
Cancer continues to be a leading cause of pediatric mortality
in the developed world, with physicians and scientists con-
stantly developing new weapons to combat it. Chemother-
apy, surgery, nutrition, and holistic medicine all have a place
in the multimodal approach that can prolong longevity and
ameliorate quality of life. As part of this armamentarium,
external beam radiation therapy (XRT) has proven to be a
safe and eﬀective technique for the management of various
malignant(andoccasionallynonmalignant)lesions.XRTcan
be used for both curative and palliative purposes; in the
latter case, children beneﬁt from decreased pain, preserved
organ function, and the maintenance of lumen patency in
hollow organs [1]. The medical team, led by a radiation
oncologist, often includes a physicist, a dosimetrist, several
radiation therapists (technologists), the patient’s primary
care pediatrician, and often an anesthesiologist to direct the
sedation and ensure patient safety [2].
Since radiation therapy is a painless procedure, many
older patients can complete their treatment without the
use of anesthesia or sedation. Parental reassurance, and
possibly the promise of a small reward afterward, is enough
motivation for many children to remain still. Clearly babies
and younger toddlers are not receptive to such enticement,
and these are the patients that make up the vast majority of
XRTanesthesiacases.Olderchildrenmaybedistressedbythe
absence of a parent next to them, but they often respond well
to pictures attached to the ceiling within their ﬁeld of view
or the presence of music in the room. Indicators that suggest
the need for anesthesia include young age, anxiety, treatment
complexity (e.g., prone position), emotional immaturity for
age, and a history of noncompliance [3].
2.AlternateSiteAnesthesiology
The provision of anesthesia for patients undergoing radio-
therapy procedures may present a deceptively simple chal-
lenge to the anesthesiologist. These cases are often very short
in duration, sometimes lasting no more than ten minutes,
and can usually be accomplished without the use of general
anesthesia. The patients are often healthy from a cardiopul-
monary standpoint although some malignancies may be
associated with other medical conditions (e.g., Trisomy 21)
which increase the likelihood of cardiac anomalies, such as
endocardialcushiondefects.Furthermore,thereisessentially
no blood loss or ﬂuid shift present. How then can we explain2 International Journal of Pediatrics
Figure 1: The linear accelerator.
the discomfort that anesthesia providers experience when
faced with performing cases in the radiation therapy suite?
In general, many clinicians experience a palpable sense
of angst when asked to do cases anywhere outside of
the “comfort zone” of the operating room. The personnel
employed in the XRT suite are well trained in their ﬁeld
of expertise; unfortunately for us, that ﬁeld has little to do
with anesthesiology. Assistance with lines, diﬃcult airways,
or anesthetic emergencies may be delayed or completely
unavailable. Your colleagues and the anesthesia technicians
might not be familiar with the location of the XRT suite,
making it diﬃcult and time-consuming to acquire personnel
support, extra drugs, or equipment. However, the greatest
source of concern seems to be the physical distance that must
be maintained from the patients. While many alternate-site
anesthetizing locations force the anesthesiologist to be at a
considerable distance from the patient, perhaps even in a dif-
ferent room (CT scanner, MRI suite), the XRT area is unique
inthatthereisnomeansofdirectlyviewingthepatientorthe
monitors. Instead, once the procedure has begun, we must
rely solely upon the use of closed circuit television monitor-
ing. While “teleanesthsia” has long been postulated as being
a possible future direction of the ﬁeld, few practitioners are
excited about being the mavericks forced to incorporate this
technology into their current practice.
3. Fundamentals of XRT
Beforeanesthesiologistscanfeelmorecomfortableproviding
anesthesia in the XRT suite, they must ﬁrst have a basic
understanding of what is accomplished there. When the
actual treatment room is ﬁrst entered, the most obvious
piece of equipment you will notice is the linear accelerator
(Figure 1). Inside of this machine, electrons are accelerated
to very high energy states within a vacuum. The electrons
are then forced to collide with a material such as tungsten,
which releases energy in the form of X-rays [4]. This energy
is then focused at speciﬁc sites within the patient in an
eﬀort to degrade the genetic material within the tumor cells.
The energy absorbed by the tissues is measured in terms
of gray (Gy), which has replaced the more antiquated unit
of rad. 1Gy is equal to the deposition of 1J/kg and is
equivalent to 100rad units [5]. While most patients receive
this type of X-ray therapy, other types of lesions respond
better to bombardment with electron, proton, or neutron
beam therapy. In any event, the anesthetic considerations are
essentially identical despite the type of subatomic particle
that is utilized.
4. Simulation
When a child is accepted as a candidate for XRT, he or she
must ﬁrst undergo a treatment planning session, referred to
as a simulation. The physical set-up of the simulation suite
is very similar to the XRT therapy room (Figure 2). However,
thesimulationmachineisincapableofdeliveringtherapeutic
doses of radiation. Instead, it is used to provide radiographs
of each treatment ﬁeld which will aid the radiation therapy
team in planning radiation doses and points of entry.
Simulation serves several functions at the outset of therapy.
(1) Simulation allows the radiation oncologist to pre-
scribe the proper treatment by reproducing the exact
conditions that will be encountered during the weeks
of therapy. The number and location of anatomic
ﬁelds that will need treatment will be decided; the
radiation therapy team may typically treat anywhere
from one to four ﬁelds, depending upon the type
and size of the lesion. Ideal patient positioning will
be also determined. Most patients can be treated
in the supine position; however, craniospinal axis
radiotherapy will necessitate the patient remaining
in the prone position throughout therapy, while two
lateral whole brain ﬁelds are supplemented with a
posterior ﬁeld of the spine [6]. This adds another
layer of challenge to the anesthetic management.
(2) Once these sites are determined, the therapist will
mark the skin with ink to denote targets for future
treatment.Thesemarkingswillremainonthepatient
for the duration of the therapy and may be reapplied
by the therapist as necessary. The markings increase
accuracy and greatly enhance the speed of the future
therapy sessions.
(3) Plaster immobilization casts of the head (Aquaplast
RTTM, Q-Fix, Avondale PA, Figure 3) and/or body
(Alpha Cradle, Smithers Medical Products Inc.,
North Canton OH, Figure 4) are made, depending
upon the sites that are to be treated. These casts make
certain that the child will not move during the treat-
ment sessions, ensuring that the radiation is directed
at its target and not at normal surrounding tissue.
Inadequate immobilization can result in treatment
failure [7, 8]a sw e l la sd a m a g et on o r m a lt i s s u e[ 9].International Journal of Pediatrics 3
Figure 2: The simulation machine.
(4) The radiation oncologist will determine if blocks will
be necessary during the treatment period. Blocks
are radio-opaque shields that are attached to the
linear accelerator (Figure 5) to shield radiosensitive
organs (e.g., kidneys and eyes) from the ionizing
radiation.
(5) Iftheteamisstillquestioningtheneedforanesthesia,
the simulation oﬀers an ideal trial without the risk of
radiation to see if the child will be cooperative and
can remain immobile during the session.
The simulation session takes place anywhere from 20
to 90 minutes, depending upon the level of cooperation of
the patient and the number and location of the ﬁelds that
needtobemarked.Mostpatientswhowillrequireanesthesia
intervention for XRT will do well during the simulation
with monitored anesthesia care (MAC). Since therapeutic
radiation is not used, the anesthesia team can remain with
the patient during the majority of the simulation. When
conventional radiographs are taken, the anesthesia and radi-
ation oncology teams can remain in the room while wearing
lead shielding or safely observe the patient through a panel
of leaded glass from an adjacent room. Medications can be
given freely throughout the procedure as dictated by patient
anxiety and motion. If general anesthesia is required, the
anesthesia machine must be placed in a location that will not
interfere with the lateral X-ray ﬁelds. Circuit hose extensions
may be needed to place the machine at an appropriate
distancefromthepatient.Attheconclusionofthesimulation
patients may be recovered in the XRT suite, provided there is
adequate nursing supervision. Alternatively, the patient can
recover in the main postanesthesia care unit.
The simulation phase may immediately be followed by
the ﬁrst treatment, but it is more common for the family
Figure 3: A premolded aquaplast.
Figure 4: A premolded alpha cradle.
Figure 5: Blocks used to shield radiosensitive organs.4 International Journal of Pediatrics
to return within the next day or two to begin the actual
radiation therapy. This gives the team adequate time to
map the coordinates of the sites that will be irradiated and
decide upon dose and duration parameters. Total dose varies
between 25 and 80Gy, with a median value of 60Gy. Lower
doses are used for hematological cancers (leukemia and
lymphoma) and seminomas; higher doses are reserved for
solid tumors such as sarcomas and gliomas. The total dose
of radiation is typically divided into 30 equal portions and
administered once daily, ﬁve days per week over a 6-week
period. Certain patients may beneﬁt from hyperfractionated
irradiation or the administration of XRT more than once
daily [10].Eachﬁeld requiresupto 90seconds ofirradiation;
after this is completed, the radiation therapists must adjust
the couch, reset the coordinates of the linear accelerator,
and change the blocks so that the next ﬁeld can be treated.
Depending upon the number of ﬁelds (typically no more
than four), the entire process can be completed in anywhere
from 5 to 20 minutes. At speciﬁed time intervals (usually
once per week), the therapists will repeat the radiographs
to ensure that the anatomic targeting of the radiation beam
is still accurate. This should add no more than another 5
minutes to the procedure.
5. Anesthetic Management of XRTTreatment
The majority of children who require anesthetic intervention
can tolerate the daily therapeutic regimen with only MAC.
Even patients who may have required general anesthesia
for the simulation typically do well with moderate sedation
(as deﬁned by the ASA Task Force, Table 1) during the
therapy phase, due to the brief time required for treatment.
One signiﬁcant exception is the child being treated for
retinoblastoma; in this case, the globe must be kept com-
pletely immobile. MAC sedation, especially if ketamine is
used (with a resultant lateral nystagmus), cannot accomplish
this [11]. The room will be evacuated during the treatment
p e r i o d ;h o w e v e r ,i ti ss a f et or e e n t e ri nb e t w e e nd o s e s ,a n d
therefore it is unusual to be away from the patient for more
than 3 minutes. Of course, any reasonable request to reenter
the room at any time should be honored by the radiation
therapist; thetreatmentcanbeaborted beforeitis completed
to allow safe entry into the room.
Parents are advised to follow fasting guidelines typical
for all ambulatory surgical cases. If the tumor or medical
condition is impairing gastric emptying, stricter guidelines
may need to be enforced. Parents are encouraged to allow
infants and children to ingest solid food and breast milk
up to 4 hours before the procedure, and clear liquids are
generally permitted up to 2 hours beforehand [13, 14]. Since
fasting guidelines vary by institution, it is suggested that
the practitioners follow the recommendations established by
their own department.
The intravenous route is the preferred method of admin-
istering medication to these patients. While intramuscular
d r u g ss u c ha sk e t a m i n ea r ee ﬀective, the repeated trauma
of a painful injection daily for six weeks is often worse
than the prospect of the XRT therapy. A large majority
of these children have either recently completed a course
Figure 6: A Huber needle used to access an intravascular port.
of chemotherapy or are receiving it concomitant with the
XRT and will therefore have an intravascular port present.
Typically the port can be accessed with a Huber needle
(Figure 6) prior to the ﬁrst treatment, and the access can
be left in place throughout the week and removed after the
week’s ﬁnal treatment. The port remains dormant over the
weekend, and the cycle repeats the following week. Parents
can apply EMLA cream (AstraZeneca, London UK) to the
site one hour before arriving Monday morning to make
the access less traumatic. Alternatively, if the patient does
not have a port, intravenous access via a peripheral vein
can be obtained Monday morning, left in throughout the
week, and removed on Friday, thereby following the same
schedule[15].Again, EMLAcangreatlyfacilitatetheprocess.
In either case, the port or catheter should be ﬂushed with
a heparin ﬂush solution (typically 300 units of heparin in
3cc of normal saline) at the conclusion of each treatment to
ensure continued patency throughout the week.
Aseptic technique is imperative when accessing a port or
placing an intravenous catheter. These children are typically
neutropenic from the XRT and/or chemotherapy, as well as
their disease state, and cannot tolerate the threat of bacterial
infection.Largecaseseriesestimatetheriskofsepsisbetween
7% [3] and up to 15% [16]. The use of propofol, which can
act as a potent culture medium for bacteria, may enhance the
risk [17].
Fortunately, the advent of short-acting sedative agents
has decreased the prevalence of such pediatric favorites
as rectal methohexital [18], chloral hydrate, and the DPT
cocktail (meperidine, promethazine, and chlorpromazine
[19]). Intravenous midazolam has been the cornerstone of
pediatricsedationsinceitsintroductionintoclinicalpractice.
The anxiolytic and amnestic proﬁle is so good that many
patients can complete their entire series of treatments with
the aid of only this drug. If this is the case,participation of an
anesthesiologist is rarely warranted [20]. The safety record of
intravenous midazolam used in the absence of other sedative
drugs is extensive. Since XRT is a painless procedure, it is
unnecessary to supplement the benzodiazepine with nar-
cotics.Therefore,withadequatemonitoringofvitalsigns,the
sedation can typically be managed by a registered nurse cre-
dentialed/trained in sedation, as per institutional protocol.International Journal of Pediatrics 5
Table 1: Deﬁnitions of clinical states of sedation as proposed by the American Society of Anesthesiologist’s task force on sedation and
analgesia by nonanesthesiologists [12].
Sedation level Characteristics
Minimal
sedation/anxiolysis
A drug-induced state during which patients respond normally to verbal commands
Cognitive function and coordination may be impaired
Ventilatory and cardiovascular functions are unaﬀected
Moderate
sedation/analgesia
A drug-induced depression of consciousness during which patients respond purposefully to verbal
commands, either alone or accompanied by light tactile stimulation
No interventions are required to maintain a patent airway, and spontaneous ventilation is adequate
Cardiovascular function is usually maintained
Deep sedation/analgesia
A drug-induced depression of consciousness during which patients cannot be easily aroused but
respond purposefully following repeated or painful stimulation
Ability to independently maintain ventilatory function may be impaired
Patients may require assistance in maintaining a patent airway, and spontaneous ventilation may be
inadequate
Cardiovascular function is usually maintained
A drug-induced loss of consciousness during which patients are not arousable, even by painful
stimulation
General anesthesia Ability to independently maintain ventilatory function is often impaired
Patients often require assistance in maintaining a patent airway and positive pressure ventilation
may be required because of depressed spontaneous ventilation or drug-induced depression of
neuromuscular function
Cardiovascular function may be impaired
Patients who require more extensive therapy often still
beneﬁt from the use of midazolam. An initial dose of
0.05mg/kg IV often provides enough sedation to allow
for the placement of monitors. If ketamine is to be used,
midazolam may decrease the incidence of postprocedure
delirium [21]. After this initial dose of midazolam, the
child should be dosed with a more potent agent to allow
for transfer to the treatment couch and placement of
therapeutic restraining devices. If necessary, midazolam can
be readministered; cumulative doses greater than 0.2mg/kg
are rarely necessary. Of course, ﬂumazenil must be readily
available whenever benzodiazepines are being administered.
When benzodiazepine therapy is insuﬃcient due to
continued patient agitation, propofol is usually the preferred
drug of choice for most anesthesiologists in the XRT suite,
especially when dealing with children. After benzodiazepine
pretreatment as previously described, an initial propofol
bolus in the range of 0.5–0.8mg/kg has been shown to
provide adequate sedation for positioning and manipulation
on the XRT couch while still allowing for spontaneous
respiration and airway control [22]. This is followed by a
continuouspropofolinfusionintherangefrom7.4mg/kg/hr
[23]t o1 0 m g / k g / h r[ 24] throughout the treatment phase.
Spontaneous eye opening was noted within 4 minutes of
discontinuingtheinfusion[23].Initialconcernsabouttachy-
phylaxistopropofol[25]havebeendisprovedbymorerecent
studies [26–28]. Thus propofol, combined with midazolam,
provides excellent therapeutic conditions throughout the
entire course of treatment [29]. Propofol has also been cited
as being an excellent stand-alone drug to use in XRT without
theneedforbenzodiazepinepremedication.Ifthepatienthas
a centrally accessed port, the likelihood of burning during
propofol administration is highly unlikely.
The infusion of the α-2 agonist dexmedetomidine in the
XRT suite has been described [30] although it has not been
widelyadopted.Themostlikelyreasonsforitsinfrequentuse
are the prolonged time needed to administer the initial bolus
(which can be as long as the entire case itself), and the fact
that pediatric administration of the drug constitutes an oﬀ-
label usage.
Ketamine is another drug that is also used successfully,
following midazolam pretreatment [31], to manage patients
in the XRT suite [32, 33]. Ketamine can be given as a
continuous infusion (25mg/kg/hr) [34], but the α-phase
serum half-life of 11 minutes [35] and the short duration
of these cases often make this unnecessary. An initial dose
of 0.5–0.75mg/kg given at the start of therapy is often all
that is required to accomplish the procedure. If the patient
becomes agitated during the treatment, a supplemental
dose of 0.25mg/kg can be given to extend the period of
cooperation. At some institutions, the use of ketamine has
become so standardized that it is used in the XRT suite in the
absence of an anesthesiologist [36].
Unlike propofol, it is not uncommon to witness tachy-
phylaxis develops to the eﬀects of ketamine. By the ﬁfth or
sixth week of therapy the child may require twice the dosage
to obtain the same eﬀect as seen during the ﬁrst or second
week.Clinicalexperiencehasshownthatrecoverytimeisnot
prolonged in the latter phases of treatment, suggesting that
the metabolism of the drug is also enhanced.
Fospropofol, a prodrug of the induction agent propofol,
has recently been approved by the FDA for use as a sedative6 International Journal of Pediatrics
agent, to be administered by practitioners trained in the
provision of anesthesia [37]. Like dexmedetomidine, its
use in the pediatric population is currently considered
an oﬀ-label usage. Fospropofol is converted in vivo by
alkaline phosphatase to release propofol, formaldehyde, and
phosphate [38]. Clinical studies suggest that an initial dose
of 6.5mg/kg, followed by a redose of 1.5–2mg/kg if needed
four minutes later, provides adequate sedation for minimally
painful procedures with statistically insigniﬁcant incidence
of side eﬀects (desaturation below 92%, hypotension 20%
below baseline [39, 40]). Burning on injection was not
reported with fospropofol, but almost all patients report a
tingling or burning sensation in the genital and perianal
area [41, 42]. While fospropofol has not yet been widely
marketed in the United States, it will be produced by the
Esai Corporation under the trade name Lusedra [43]. Future
clinical studies will determine its suitability in the XRT
suite although its pharmacodynamic proﬁle seems ideal for
pediatric oncology cases.
When general anesthesia is required, the brevity of
the procedure must be kept in mind when choosing an
inductionagent.Amusclerelaxantmaynotbenecessary(the
exception, as stated before, is XRT for retinoblastoma, which
requires paralysis of the extraocular muscles). The subglottic
swelling that may develop with repeated daily intubations
canbeobviatedbytheuseofasupraglotticairwaysuchasthe
LMA (LMA North America Inc., San Diego, CA), [44, 45].
Antiemetic therapy is suggested at the conclusion of each
day’streatment.TheemeticeﬀectsofXRTcanexacerbatethe
nausea from chemotherapy and stress and result in vomiting
in the recovery area. Ondansetron 0.1mg/kg is perhaps the
agent of choice for most practitioners, but others report
the use of steroids or phenothiazines with good results.
Haloperidol, while showing some promise for the relief of
postoperative nausea and vomiting, has been shown to be of
little value in the XRT suite [46].
6.Nonpharmacological Methods ofAnxiolysis
Some practitioners use psychosocial methods either in lieu
of or as a supplement to pharmacologic sedation. These
interventions may begin before the child enters the XRT
suite. One center constructed an imitation linear accelerator
in the children’s playroom, complete with a large doll who
received mock treatments. The children were allowed to act
as the physicians and via transference were able to quell
some of their apprehensions [47]. Other reports describe
the use of music and videos [48], gradually immersing the
patient by slowly introducing him/her to what is expected,
rewarding each successful step [49], and using an interactive
Barney character [50] in an attempt to keep patients calm
and motionless. While the last study showed a statistically
signiﬁcant decrease in patients’ heart rates, there was no
diﬀerence in the incidence of observed behavioral distress
or the need for sedation. Therefore, it is diﬃcult to draw
ﬁrm conclusions about the utility of these techniques.
Furthermore, a busy XRT service might not be able to devote
the necessary time and patience to foster the atmosphere
necessary for such methods.
Figure 7: A remote monitor bank.
7. MonitoringduringXRT
Remote monitoring of the patient receiving XRT therapy has
progressed to the point where it is on par with technology
found in the operating room. The days of rigging together
makeshift monitoring devices [51]h a v eb e e ns u p p l a n t e db y
the use of crystal clear closed circuit monitoring. The typical
conﬁguration (Figure 7)u s e st w oc a m e r a st op r o v i d ev i s u a l
monitoring. Each camera is controlled by switches next to
the television screens, allowing individual control of zoom
and focus [52]. One camera is directed at the patient to
observe for consistent breathing and the absence of other
movements. The other camera is focused upon the monitors,
which typically include (at minimum) the ASA standards
of EKG, NIBP, and pulse oximetry and qualitative end-
tidal CO2. If the patient is receiving general anesthesia, the
ﬁeld of vision can be widened to include the ventilator and
anesthesia machine as well. A microphone is also present to
transmit the pulse oximeter tone. Remote audio monitoring
of an esophageal stethoscope has been reported [53]b u t
is not widely practiced. Documentation, either electronic
or manual, should be completed from the initiation of
sedation until the patient is transferred to a postanesthesia
care provider.
8. XRT in AlternateSites
The provision of radiation therapy is not limited solely
to the XRT suite; indeed, it has begun to make inroads
into the operating room. Brachytherapy or the intracavity
implantation of radiotherapeutic material (e.g., radioactive
prostate seeds and intrauterine isotopes) has been used suc-
cessfully for years. Patient fears about “becoming radioactive”
are largely exaggerated; because the radioactive material is
sealed, only a small area around the site will be radioactive.
The body as a whole will not emit radioactivity and it
is generally safe for the patient to resume contact with
others. In contrast, a patient receiving external beam XRT
will emit no radioactivity whatsoever. Patients who receive
intravenous radioactive isotopes, however, will continue to
discharge radioactive material in their saliva, sweat, andInternational Journal of Pediatrics 7
Figure 8: The gamma knife machine (courtesy of Elekta).
urine. The duration of this is dependent upon the half-life
of the agent used [54].
Surgeons, radiation oncologists, and anesthesiologists
can also work as a team to provide intraoperative radiation
therapy (IORT) [55]. This is especially useful for tumors
which cannot be fully resected or have a high probability
of local recurrence. In these cases, the treatment begins in
the operating room, where surgical exposure and debulking
of the tumor occurs. The wound is then covered, and the
patient is then transported to the XRT suite to receive high-
dose external beam radiation directly to the exposed tissue.
The child is then returned to the operating room for closure
of the surgical site. These cases, typically performed under
general anesthesia, require a great degree of coordination
between all parties involved. Transport of the patient with an
open surgical site requires careful attention to maintaining a
sterile ﬁeld as well as continued provision of anesthesia and
analgesia. The patient should be stable from a cardiovascular
standpoint prior to leaving the operating room, and full
monitoring, airway, and PALS supplies should accompany
the patient during the transit phase [56].
Stereotactic radiosurgery is another radiation therapy
venue where anesthesiology services may be necessary. This
procedure is used to treat conditions as diverse as malig-
nancies, arteriovenous malformations, acoustic neuromas,
and trigeminal neuralgia. The most widely used device,
the Gamma Knife (Elekta Instruments Inc., Stockholm,
Sweden), focuses 201 beams of gamma radiation (derived
from cobalt-60) upon the lesion [57] (Figure 8). In contrast
toXRTderivedfromalinearaccelerator,onlyasinglesession
of radiotherapy is needed to treat the disease. However, the
patientmayrequireseveraldosesadministeredconsecutively,
each targeted to a diﬀerent surface of the lesion.
Anesthetic management is much like what has been
described for traditional XRT. MAC usually provides suf-
ﬁcient anesthesia although general may be required for
very young patients and other special circumstances. The
patient must ﬁrst have the stereotactic frame placed which
involves having four anchoring screws placed into the soft
tissue of the head. The neurosurgeon or oncologist applying
the frame will use local anesthesia to numb the areas;
however, a small dose of ketamine or propofol immediately
beforehand will make the procedure less traumatic. The
child will then proceed to the MRI suite, where scans will
be taken of the patient’s brain with the external frame in
place. It is imperative that all practitioners are aware of
the hospital’s protocols for MRI safety. The patient will
likely be transferred to an MRI compatible stretcher, and
all monitoring devices will be replaced with appropriate
alternatives. Oxygen cylinders must be removed from the
vicinity of the magnet. The patient’s caregivers must be
interrogated about the presence of any metallic implants,
and the medical staﬀ must remove any objects that may
become a projectile hazard. Since the frame will limit access
to the patient’s airway, it is imperative that the patient is
transported with the appropriate tools to quickly remove the
frame in case airway access is necessary. If a vascular lesion is
present, the child may also be taken to the neuroangiography
suite for a diagnostic cerebral angiogram to further elucidate
the anatomy. Afterward, the patient is permitted to rest while
the physicians and physicists perform a 3D reconstruction of
the MRI, plotting the coordinates that will most eﬀectively
target the intracranial pathology. The child is then placed
into the Gamma Knife unit where several doses of radiation
are administered (each lasting from 4 to 10 minutes). Upon
completion, the stereotactic frame is removed, antibiotic
ointment is applied to the puncture sites left by the screws,
and the patient is transported to the recovery area.
The Cyberknife Robotic Radiosurgery System (Accuray
Inc., Sunyvale CA) oﬀers the clinical advantage of being able
to treat tumors in any part of the body, freeing it from the
intracranial restrictions of the Gamma Knife unit. Other
enhancements include the Synchrony Respiratory Tracking
System, a tracking software program that compensates for
targetmovementcausedbynormalrespiration.Thisobviates
the need for a restrictive stereotactic device to be attached
to the child, the primary reason anesthesia assistance is
often requested for these patients. Thus, the absence of the
frame and the freedom to relax and breathe normally mean
older children can often tolerate this procedure with no
pharmacological sedation.
9. Conclusion
Alternate-site anesthesiology has become more routine over
the last decade as hospitals realize they can reduce costs
and increase eﬃciency by “outsourcing” some types of
cases out of the operating room. While some clinicians
still feel uncomfortable emerging from the “protection”
of the OR, others have embraced the chance to expand
their practice beyond its traditional borders. XRT oﬀers
the anesthesiologist both a physical layout and a patient
population that can be challenging initially but ultimately
extremely rewarding.
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